PG0026 is identified as a novel C-terminal signal peptidase responsible for cleaving the C-terminal domain (CTD) signal peptides of virulence factors such as gingipains, which are critical for P. gingivalis pathogenicity . Key features include:
Catalytic Activity: PG0026 cleaves CTD signals after secretion, enabling protein maturation and surface localization of virulence factors .
Secretion System: Part of a non-classical Type IX secretion system (T9SS) unique to Bacteroidetes, facilitating the transport of CTD-containing proteins across the outer membrane .
Genetic Essentiality: Knockout mutants of PG0026 result in defective processing of CTD proteins, impairing bacterial virulence .
Recombinant studies focus on PG0026’s role in virulence and host interactions:
PG0026-processed virulence factors contribute to periodontal pathogenesis by:
Immune Modulation: Gingipains degrade cytokines (e.g., IL-8) and complement components, impairing neutrophil recruitment .
Biofilm Formation: PG0026-deficient mutants show altered LPS O-antigen chains, reducing biofilm stability .
Systemic Effects: P. gingivalis LPS and gingipains promote atherosclerosis via TLR2/4 activation .
Structural Studies: High-resolution structures of PG0026 are needed to design inhibitors.
Recombinant Expression: Limited data exist on recombinant PG0026 production; further optimization could aid functional assays.
Therapeutic Potential: Targeting PG0026 with monoclonal antibodies or small-molecule inhibitors may disrupt P. gingivalis pathogenicity .
KEGG: pgn:PGN_0515
STRING: 431947.PGN_0515